chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Right tonic-clonic seizure with left facial, eye twitching lasting 2 minutes. Seizure began the evening on the day when vaccines were given, Patient taken to Peditric ER and admitted.  7/8/09 Medical records received DOS 6/30/09 to 7/7/09. Assessment: New onset seizure. Parent reports patient shaking leg fast in her sleep, jerking a lot, trouble waking her up, lip looks crooked. Referred to neurologist for EEG.  7/17/09 Hospital records received DOS 6/30/09 to 7/4/09. Assessment: Seizure-like activity. Presented at ER after seizure-like episode. Fussiness, fell asleep early, jerking movements of trunk, left-side mouth twisting with spitting noises. Rapid twitching of left arm and left leg. Very sleepy and difficult to arouse. Uncomfortable.  8/18/09 ICD-9 Codes: 780.39 Seizure(s) other, 780.60 Fever, 288.60 Leukocytosis unspecified.
Mom state pt recvd DTP/OPV/MMR/HIB 6MAY92 & @ 7PM on 6MAY92 fever devel 103 then @ about 2AM 7MAY92 vomiting begin x 2 followed by diarrhea @ 11AM 7MAY92; mom stated temp down & vomiting stopped since this AM;
Sharpe pain to chest and back.; Sharpe pain to my chest and back; Radiating pain in neck and left arm; Radiating pain in neck and left arm; Palpitations; 3rd Booster dose; This is a spontaneous report from a contactable nurse, the patient. A 40-year-old male patient received the third dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: 301358A) via an unspecified route of administration in the left arm on 30Sep2021 at 14:15 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes mellitus (DM). Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient had no known allergies. The patient received unspecified medication within two weeks of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received  the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on 03Feb2021 at 10:45 (at the age of 40-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the left arm on 24Feb2021 at 10:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. On 05Oct2021 at 14:30, the patient experienced sharp pain in his chest and back, radiating pain in neck and left arm and palpitations. On 28Sep2021, the patient underwent PCR test via nasal swab and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, the patient had been tested for COVID-19. The clinical outcome of the events sharp pain in chest and back, radiating pain in neck and left arm and palpitations was not resolved at the time of this report.
3-4 hours later I started to feel the pain at the injection site and chills on my all my body. I had to put on two blankets, two pajamas, and turn the heater on. All night long I had pain at the injection site but more pain. The next day in the morning I looked at the injection site and I had bump, redness, and hot at the injection site. I still felt chills. I felt really sleepy. All my body really tired. I could feel a pain in all of my joints. I was like that for two days at the beginning. After about two days, I felt my hand really rare and a lot of pain. I tried to open the milk and bottled water but I couldn't it was really painful. I had to ask my husband for help. I had pain on my whole body like that with pain for a couple days. The chills I had about 4 days. Later, I still feel my hands in constant pain. I wear compression socks because I walk too much at my job but I couldn't put them on. My husband had to put them on me. When I was working I bought compression gloves after that I still had the same pain for 24 hours a day on my hands. Every morning my hands felt swollen. I have a hard time working to pull, to carry, to grab. On November 12, 2022, I decided to go to the doctor. They told me to do ice pack, hot pack, elevate hands, and for pain to take TYLENOL but nothing worked. I tried putting arthritis ointment for pain. I went back to doctor on December 22nd, 2022 and they gave me prednisone for two weeks. The doctor told me I had muscular inflammation and tendonitis in both wrists. The medication helped but when I finished taking it the pain came back again. I have an upcoming appointment on February 22, 2023 with my doctor.
Vaccinated morning of 10/17/2022. At work at desk on 10/19/2022 and had sudden onset of right side chest pain and shortness of breath. Blood pressure was elevated at 158/104. Transported to emergency department . Referred to cardiology for further workup.
Information has been received from a practitioner nurse concerning a 11 or 12 years old female patient who about a year, in approximately 2010, was vaccinated intramuscularly, 0.5 mL with the first dose of GARDASIL (Lot# and expiration not reported). The nurse reported that about a year, in approximately 2010, the patient became dizzy, hot and felt sick after received her first injection of GARDASIL. The patient sought unspecified medical attention. Therapy with GARDASIL was discontinued about a year ago, in approximately 2010, and not reintroduced. No treatment was given for this adverse event. The patient recovered shortly thereafter. Additional information has been requested.
Within hours of receiving shot, the pt suffered pruritic erythematous swelling of 10 x 15 cm with warmth and pain to touch. Pt also experienced cold sweats while sleeping at night for 3 nights. Pt self treated with ASA with not much relief. Pt is recovering.
Mother of child reports he had hives about 21:30, post vax. No treatment.
Extreme fatigue; Pain; Stomach ache; Chills; This spontaneous case was reported by a consumer and describes the occurrence of FATIGUE (Extreme fatigue), CHILLS (Chills), PAIN (Pain) and ABDOMINAL PAIN UPPER (Stomach ache) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 013A21A and 016B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 26-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 26-Mar-2021, the patient experienced CHILLS (Chills). On 26-Apr-2021, the patient experienced PAIN (Pain) and ABDOMINAL PAIN UPPER (Stomach ache). On an unknown date, the patient experienced FATIGUE (Extreme fatigue). At the time of the report, FATIGUE (Extreme fatigue) had not resolved, CHILLS (Chills) had resolved and PAIN (Pain) and ABDOMINAL PAIN UPPER (Stomach ache) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications were reported.  No treatment medications were reported.   This case was linked to US-MODERNATX, INC.-MOD-2021-098231 (E2B Linked Report). This case was linked to MOD-2021-030367 (Patient Link).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-098231:Crosse linked to MOD-2021-029709 and MOD-2021-098231 (4 cases created for 1 consumer only reporting herself)
pain in her arm; I have lost my appetite/No longer hungry; diarrhea; The shot center where the shot was is very sore and a very inflamed; The shot center where the shot was is very sore and a very inflamed; fatigued; This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (pain in her arm), DECREASED APPETITE (I have lost my appetite/No longer hungry), DIARRHOEA (diarrhea), VACCINATION SITE INFLAMMATION (The shot center where the shot was is very sore and a very inflamed) and VACCINATION SITE PAIN (The shot center where the shot was is very sore and a very inflamed) in a 76-year-old female patient who received mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (batch no. 204F23A) for COVID-19 prophylaxis. The occurrence of additional non-serious events is detailed below.     Previously administered products included for COVID-19 prophylaxis: Moderna Covid-19 Vaccine (023M20A) on 16-Feb-2021, Moderna Covid-19 Vaccine (023M20A) on 16-Mar-2021, Moderna Covid-19 Vaccine (939305) on 07-Nov-2021, MODERNA COVID-19 VACCINE (038A22A) on 14-May-2022, Moderna Covid-19 Vaccine (014H22A) on 24-May-2022 and Moderna Covid-19 Vaccine (059?22A) on 14-Oct-2022. Past adverse reactions to the above products included No adverse event with MODERNA COVID-19 VACCINE, Moderna Covid-19 Vaccine, Moderna Covid-19 Vaccine, Moderna Covid-19 Vaccine, Moderna Covid-19 Vaccine and Moderna Covid-19 Vaccine. Concurrent medical conditions included Asthma, Hypertension and Diabetes.    On 17-Oct-2023, the patient received seventh dose of mRNA-1273.815 (SPIKEVAX 2023-2024 PFS) (unknown route) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (pain in her arm), DECREASED APPETITE (I have lost my appetite/No longer hungry), DIARRHOEA (diarrhea), VACCINATION SITE INFLAMMATION (The shot center where the shot was is very sore and a very inflamed), VACCINATION SITE PAIN (The shot center where the shot was is very sore and a very inflamed) and FATIGUE (fatigued). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and LOPERAMIDE HYDROCHLORIDE (IMODIUM) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (pain in her arm), DIARRHOEA (diarrhea), VACCINATION SITE PAIN (The shot center where the shot was is very sore and a very inflamed) and FATIGUE (fatigued) had not resolved and DECREASED APPETITE (I have lost my appetite/No longer hungry) and VACCINATION SITE INFLAMMATION (The shot center where the shot was is very sore and a very inflamed) outcome was unknown.            No concomitant medication was reported.   Patient was putting ice packs on her arm.
Low platelet count in blood. Had bone marrow test that showed marrow is producing plenty of platelets, the platelets are being destroyed or consumed internal to my body.
tiredness; a little headache; soreness at the injection site; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the parent.  A 14 year-old female patient received bnt162b2 (COMIRNATY), administration date 06Jan2022 (Batch/Lot number: unknown) as dose 3 (booster), single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Manufacturer: Unknown, Dose number: 1st), for Covid-19 immunization; Covid-19 vaccine (Manufacturer: Unknown, Dose number: 2nd), for Covid-19 immunization. The following information was reported: FATIGUE (non-serious) with onset 07Jan2022, outcome "unknown", described as "tiredness"; HEADACHE (non-serious) with onset 07Jan2022, outcome "unknown", described as "a little headache"; VACCINATION SITE PAIN (non-serious) with onset 07Jan2022, outcome "unknown", described as "soreness at the injection site".  The lot number for bnt162b2 was not provided and will be requested during follow up.
In Sep2021 I noticed a small quarter-sized bald patch on the back of my head.; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 29 year-old female patient (not pregnant) received bnt162b2 (BNT162B2), administration date 22Apr2021 (Lot number: FW0170) at the age of 28 years as dose 2, single for covid-19 immunisation. Relevant medical history included: "Behavioral health" (unspecified if ongoing), notes: other medical history: Behavioral health; "asthma" (unspecified if ongoing), notes: other medical history: asthma. Concomitant medication(s) included: LAMICTAL; CITALOPRAM. Past drug history included: Augmentin, reaction(s): "Allergy: Augmentin", notes: known allergies: Augmentin. Vaccination history included: Bnt162b2 (Dose Number: 1, Batch/Lot No: ER8733), administration date: 01Apr2021, when the patient was 28 years old, for Covid-19 Immunization. The following information was reported: ALOPECIA (non-serious) with onset Sep2021, outcome "not recovered", described as "In Sep2021 I noticed a small quarter-sized bald patch on the back of my head.". The event "in sep2021 i noticed a small quarter-sized bald patch on the back of my head." was evaluated at the physician office visit. Therapeutic measures were taken as a result of alopecia.  Additional information: The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient treated with corticosteroid injections and topical treatments. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient been tested for COVID-19.  Follow-up attempts are completed. No further information is expected.
Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 04-Mar-2022; Patient received vaccine past its 30-days expiry date; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30-days expiry date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 04-Mar-2022) in a 19-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 066H21A) for COVID-19 vaccination.     Acute illness at the time of vaccination and up to one month before was reported as unknown.  Chronic or long-standing health conditions was reported as unknown.     On 04-Mar-2022 at 9:03 AM, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .25 milliliter. On 04-Mar-2022 at 9:03 AM, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30-days expiry date). On an unknown date, the patient experienced PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 04-Mar-2022). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient received vaccine past its 30-days expiry date) and PRODUCT STORAGE ERROR (Vaccine went into 2-8 Celsius thaw state on or about 24-Dec-2021 and administered on 04-Mar-2022) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications were provided by reporter.   On 04-Mar-2022 at 09:03:07, patient received an expired booster dose.  It was reported that vaccines went into 2-8 C thaw state on or above 24-Dec-2021 and were administered up until the expiry date of 04-Apr-2022.  Prescriptions, over the counter medications, dietary supplements or herbal remedies being taken at time of vaccination or at the time of the adverse event were reported as unknown.  Other vaccines given on the same day as Moderna COVID-19 vaccine and other vaccines received within one month prior to any dose of Moderna COVID-19 vaccine were reported as unknown.  No treatment medications were provided by reporter.   This case was linked to MOD-2022-542869 (Patient Link).
Pt reported previous adverse reaction to an antibiotic that she recalls giving her hives.  Due to this we observed her for 30 minutes following administration of vaccine.  About 25 minutes into her observation period she began developing hives on her forearms and wasn't feeling her normal self.  She denied any respiratory symptoms but was continuously clearing her throat and when asked if she normally did that, she stated that she did not.  Decision was made to take vital signs and administer 50mg of IM Diphenhydramine.  She was agreeable to this plan .  After administering Diphenhydramine, we continued to monitor her vitals and had her stay another 45 minutes for observation.  Hives resolved and vital signs remained within normal limits.  Patient was education on allergic  reactions and she to seek medical care.  Patient verbalized understanding and felt  back to her normal self.
1.5 hours after vaccine, staff member became hot/flushed/dizzy. C/o HA, itching, episodes of flushing/dizziness.
sore arm; very tired; fever; This is a spontaneous report from a contactable other healthcare professional reporting for herself. A 66-year-old female patient received the first dose of bnt162b2 (BNT162B2, lot number EL3246, expiry date: not reported), via an unspecified route of administration, on 15Jan2021 04:45 AM at a single dose on the left arm for COVID-19 immunization. Facility type vaccine was Other. The patient was not pregnant. The patient did not receive other vaccines in four weeks. She had no other medications in two weeks. The patient did not have covid prior to vaccination and was not tested for covid post vaccination. Medical history included known allergies: PCN (penicillin). Concomitant medications were none. The next day, on 16Jan2021 02:15 PM, the patient experienced sore arm, very tired and fever. The patient took Tynol in response to the adverse events. Outcome of the events was recovered on an unspecified date in Jan2021.
showed things were messed up/hardly any output; This spontaneous case was reported by a patient family member or friend (subsequently medically confirmed) and describes the occurrence of PROTEIN TOTAL INCREASED (protein really high), BLOOD SODIUM ABNORMAL (sodium abnormal) and LABORATORY TEST ABNORMAL (showed things were messed up/hardly any output) in an 80-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 040B21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  The patient's past medical history included Indwelling catheter management (due to urinary retention). Concurrent medical conditions included Urinary retention, Diabetes and COPD. Concomitant products included METFORMIN for an unknown indication.    On 15-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Apr-2021, the patient experienced protein really high, sodium abnormal and LABORATORY TEST ABNORMAL (showed things were messed up/hardly any output) (seriousness criterion hospitalization). The patient was hospitalized from sometime in April 2021 to 24-Apr-2021 due to  LABORATORY TEST ABNORMAL. On 24-Apr-2021, LABORATORY TEST ABNORMAL (showed things were messed up/hardly any output) had resolved. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 20-Apr-2021, Blood sodium: abnormal abnormal. On 20-Apr-2021, Laboratory test: hardly any output abnormal. On 20-Apr-2021, Protein total: really high High.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication includes medication for blood sugar.  The patient was transported by ambulance to the hospital, admitted, and remained hospitalized for four days. He was released from the hospital on 24-Apr-2021. As per the patient wife, the patient is now on hospice. The wife believes this is due to the vaccine.  The patient wife states that neither she nor her husband will be getting their second dose of the vaccine, which is scheduled for 13-May-2021.   This case was linked to MOD21-088053 (E2B Linked Report).; Sender's Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded. MOD21-088053:case for caller
Presented to ED with fever, chills, bodyaches and shortness of breath on 8/16/21. Onset was 8/12/2021. Did receive the J&J vaccine. Was placed on 4L and given tylenol, dexamethasone, morphine and zofran. Diagnosed with COVID-19 pneumonia with hypoxia and admitted. Ceftriaxone, doxycycline, dexamethasone, Lovenox,and remdesivir started. Repeat/follow-up chest x-ray obtained on  08/19/2021 did not show any worsening pathology.  PRN tessalon perles was given for distressing cough. He continued to maintain adequate respiratory saturations on ambient air without need for supplemental oxygen therapy throughout his hospital stay.  The patient was ultimately discharged home in stable, improved condition.
Child developed an ileocolic intussusception 3/5/07. To surgery on 3/6/07. 04/03/07-records received from facility DC DX: Intussusception. Colicky abdominal pain. No bloody stool. Acute bilious vomiting.  Surgical procedure:laparotomy, reduction of intussusception, appendectomy. Post operative diagnosis:ileocolic intussusception.
Tingling sensation of tongue and mouth. BP 148/75 -- > 162/81. EpiPen given at 11:09AM, Benadryl 50 mg given in right arm at 11:12AM. 911 called at 11:16AM, patient taken to emergency room.
Status Dermatitis has cleared up after the vaccine; Fatigue after first dose of vaccination; This spontaneous case was reported by a consumer and describes the occurrence of THERAPEUTIC RESPONSE UNEXPECTED (Status Dermatitis has cleared up after the vaccine) and FATIGUE (Fatigue after first dose of vaccination) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     The patient's past medical history included Stasis dermatitis (since last fall, red rash type on legs plus peeling of the skin.).    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced FATIGUE (Fatigue after first dose of vaccination). On an unknown date, the patient experienced THERAPEUTIC RESPONSE UNEXPECTED (Status Dermatitis has cleared up after the vaccine). At the time of the report, THERAPEUTIC RESPONSE UNEXPECTED (Status Dermatitis has cleared up after the vaccine) and FATIGUE (Fatigue after first dose of vaccination) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medication details were provided. No treatment medication details were provided. Status Dermatitis has cleared up after the vaccine first dose.   This case was linked to MOD-2021-079474 (E2B Linked Report).   Most recent FOLLOW-UP information incorporated above includes: On 20-Apr-2021: Follow up information received included no significant information updated. On 30-Apr-2021: Follow up received included no new significant information updated. On 25-May-2021: Follow up information received included no new significant information. On 03-Jun-2021: Follow up received included no new significant information updated. On 27-Jul-2021: Follow up received included no new significant information.; Sender's Comments:  MOD-2021-079474:Second dose of vaccine case.
Patient admitted to hospital via ED 9/7/21. COVID test positive 9/7/21. Deceased 9/15/21
Headache; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of HEADACHE (Headache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 015M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 15-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced HEADACHE (Headache). At the time of the report, HEADACHE (Headache) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant medications were not reported. Treatment information in response to events was not provided.
Patient developed a rash of face, trunk, back and elbows 6 days after receiving vaccination.